Review: Anti-infectives recent developments in the antiviral therapy of influenza

Expert Opinion on Therapeutic Patents

Volumn 5, Issue 8, 1995, Pages 793-803

  Whittington, Andrew ^a   Bethell, Richard ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; NUCLEOSIDE DERIVATIVE; SIALIDASE INHIBITOR;

DRUG DEVELOPMENT; DRUG STRUCTURE; INFLUENZA; PATENT; REVIEW; SYNTHESIS;

EID: 0029152079     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.5.8.793     Document Type: Article

References (71)

1. diagnosis, management and pro-phylaxis
2. Resistance of influenza A virus to amantadine and rintantadine: results of one decade of surveillance
3. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families
4. Rapid in vivo development of influenza resistance to amantadine and rimantadine
5. Virulence of rinaantadine-resistant human influenza A (H3N2) viruses in ferrets
6. The importance of virus drug-resistance in the treat-ment of influenza A with rimantadine
7. Drug resistance and mechanismsof action on influenza A viruses
8. Differences inside effects of amantidine and rimantidine relate to differences in pharmacokinetics
9. Potential agents in the treatment of influenza
10. HALL CE:Lack of effect of oral ribavirin in naturally occuring influenza A virus (H1N1) infection
11. Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1 Ni) and B/Texas 1/84
12. Le vaccin antigrippal: Revue bibliographique
13. Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithilium
14. PENN CR: 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective Inhibitor both of the sialiehse (neuratniniriase) and of growth of a wide range of influenza A and B viruses in vitro
15. Twice daily intranasal GG167 for experi-mental influenza A
16. Anti-infectives overview: the development of potential anti-influenza drugs
17. Influ-enza virus hemagglutinin with multthasic cleavage site Is activated by furin
18. Enhancement of theInfectivity of influenza A and B viruses by proteolytic cleavage of the haemagglutinin polypeptide
19. Entry and ttncoating of enveloped viruses
20. Structure of influenza haemagglutinin at the pH of membrane fusion
21. A spring loaded mechanism for theconformational change of influenza hemagglutinin
22. Structural domains and organ-izational conformation involved in the sorting and transport of influenza virus transmembrane proteins
23. Crystal structure of influenza virus hemagglutinin in complex with high-affinity receptor analogs
24. Design and evaluation of a tightly binding fluorescent ligand for influenza A hemagglutinin
25. Monovalent sialosides that bind tightly to influenza A virus
26. PAULSON JC: Synthesis of cluster sialoside inhibitors for influenza virus
27. Ligand recognition by influenza virus
28. Molecular recognition of biva-lent sialosides by influenza virus
29. Polyacrylamides bearing pendant a-siabtside groups strongly inhibit agglutination of erythrocytes by influenza virus
30. Synthetic polymeric inhibitors of influenza virus receptor-binding activity suppress virus replication
31. GIL-BERT JH BEDNARSKI MD: Polymerized liposomes con-taining C-glycosides of sialic add: potent inhibitors of influenza virus in vitro infectivity
32. Dextran sulfate inhibits fusion of influenza virus and cells expressing influenza hemaggiutlnin with red blood cells
33. vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulphonic add pointers interacting with virus-oell bind-ing and/or fusion
34. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones
35. The kinetics of the acid-induced conformational change of influenza virus haemagglutinin can be followed using 1,1'-bis(4-anil-ino-5-naphthalene sulphonic add)
36. Inhibition of influ-enza virus A/WSN replication by serine protease inhibi-tors and anti-protease antibodies
37. The action of adamantanarnines against influ-enza A viruses: inhibition of the M2 ion channel pro-tein
38. L1ESCH JM, ZINK DL, RAGH00-BAR SL, I IELMS GL, SINGH SB: Isolation and structure of flutirnide, a novel endonuclease inhibitor of influenza virus
39. Total synthesis of flutimide, a novel endonu-clease inhibitor of influenza virus
40. Inhibition of cap (m7GpppiEm)-dependent endonudease of influenza vi-rus by 4-substituted 2,4-dioxobutanoic acid corn-pounds
41. The search for anti-influenza compounds with spedfic reference to LY217896 and its sodium salt
42. The intracellular formation of a mononucleotide of the anti-influenza agent 1,3,4-thiadiazole-2-yi cyanamide (LY217896)
43. Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans
44. NUS-INOFF-LEHRMAN S, AL NAKIB W, STABLES JN, PURIFOY DJM, POWELL KL, DARBY G: Inhibition of influenza A and B viruses by 2'-deoxy-2'-fluroribosides
45. Purine 2'-deoxy-2' fluororibosides as anti-influenza virus agents
46. Structure of theinfluenza virus glycoprotein antigen neuraminidase at 2
47. Structure of thecatalytic and antigenic sites in influenza virus
48. The structure of the complex between influenza virus neuraminidase and sialic add, the viral receptor
49. Three dimensional structure of Influenza A N9 neuraminidase and its complex with the inhibitor 2-deotry 2,3-dehydro-N-acetyl neuraminic acid
50. Evidence for a sialosyl cation transition state complex in the reaction of sialidase from influenza
51. Catalysis by Two sialidases with the same fold but different stereo-chemical courses: a mechanistic comparison of the enzymes from influenza A virus and Salmonella ty-phimurium
52. Ra-tional design of potent sialidase-based inhibitors of influenza virus replication
53. Structures of aromatic inhibitors of influ-enza virus neuranainidase
54. 4,6-Dibenzamidopyrazolo[3,4-d]pyrimid-Me is a highly selective inhibitor of cytomegalovirus adsorption to cells
55. New antiviral antibiotics, Kistamicins A and B
56. Pinacidil opens K+-selective channels causing hyperpolarization and relaxation
57. Effect of the virostaticNorakin (triperi•den) on influenza virus activities